SEARCH

SEARCH BY CITATION

References

  • 1
    Kurita H, Osada H, Shimizu K, Tachimori H. Bipolar disorders in mentally retarded persons with pervasive developmental disorders. J Dev Phys Disabil 2004;16:377389.
  • 2
    Kerbeshian J, Burd L. Case study: Comorbidity among Tourette's syndrome, autistic disorder, and bipolar disorder. J Am Acad Child Adolesc Psychiatry 1996;35:681685.
  • 3
    Steingard R, Biederman J. Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J Am Acad Child Adolesc Psychiatry 1987;26:932935.
  • 4
    Komoto J, Usui S, Hirata J. Infantile autism and affective disorder. J Autism Dev Disord 1984;14:8184.
  • 5
    Sovner R, Hurley AD. Do the mentally retarded suffer from affective illness? Arch Gen Psychiatry 1983;40:6167.
  • 6
    Wing L. Asperger's syndrome: A clinical account. Psychol Med 1981;11:115129.
  • 7
    Fombonne E, du Mazaubrun C. Prevalence of infantile autism in four French regions. Soc Psychiatry Psychiatr Epidemiol 1992;27:203210.
  • 8
    DeLong R, Nohria C. Psychiatric family history and neurological disease in autistic spectrum disorders. Dev Med Child Neurol 1994;36:441448.
  • 9
    Wozniak J, Biederman J, Faraone SV, et al. Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry 1997;36:15521559; discussion 9–60.
  • 10
    Lainhart JE, Folstein SE. Affective disorders in people with autism: A review of published cases. J Autism Dev Disord 1994;24:587601.
  • 11
    Nagaraj R, Singhi P, Malhi P. Risperidone in children with autism: Randomized, placebo-controlled, double-blind study. J Child Neurol 2006;21:450455.
  • 12
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004;114:e634–e641.
  • 13
    Tramontina S, Zeni CP, Ketzer CR, Pheula GF, Narvaez J, Rohde LA. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: A pilot randomized clinical trial. J Clin Psychiatry 2009;70:756764.
  • 14
    Findling RL, Nyilas M, Forbes RA, et al. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: A randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2009;70:14411451.
  • 15
    Tohen M, Kryzhanovskaya L, Carlson G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007;164:15471556.
  • 16
    DelBello MP, Kowatch RA, Adler CM, et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006;45:305313.
  • 17
    Haas M, Delbello MP, Pandina G, et al. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: A randomized, double-blind, placebo-controlled study. Bipolar Disord 2009;11:687700.
  • 18
    Biederman J, Mick E, Faraone SV, Wozniak J, Spencer T, Pandina G. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: A post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study. Clin Ther 2006;28:794800.
  • 19
    Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry 2005;58:589594.
  • 20
    Frazier JA, Biederman J, Jacobs TG, et al. editors. Olanzapine in the treatment of bipolar disorder in juveniles, Chicago , Illinois : American Psychiatric Association, 2000.
  • 21
    Biederman J, Mick E, Spencer TJ, Dougherty M, Aleardi M, Wozniak J. A prospective open-label treatment trial of ziprasidone monotheray in children and adolescents with bipolar disorder. Bipolar Disord in press.
  • 22
    Biederman J. An open-label trial of aripiprazole in Youth with bipolar disorder. Biol Psychiatry 2006;59:25S.
  • 23
    Biederman J, Mick E, Hammerness P, et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-aged children. Biolog Psychiatry 2005;58:589594.
  • 24
    Wozniak J, Mick E, Waxmonsky J, Kotarski M, Hantsoo L, Biederman J. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. J Child Adolesc Psychopharmacol 2009;19:539545.
  • 25
    Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 1978;133:429435.
  • 26
    Gracious BL, Youngstrom EA, Findling RL, Calabrese JR. Discriminative validity of a parent version of the Young Mania Rating Scale. J Am Acad Child Adolesc Psychiatry 2002;41:13501359.
  • 27
    Youngstrom EA, Danielson CK, Findling RL, Gracious BL, Calabrese JR. Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol 2002;31:567572.
  • 28
    Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:10311037.
  • 29
    Lachar D, Bailley SE, Rhoades HM, et al. New subscales for an anchored version of the brief psychiatric rating scale: Construction, reliability, and validity in acute psychiatric admissions. Psychol Assess 2001;13:384395.
  • 30
    Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766771.
  • 31
    National Institute of Mental Health. CGI (Clinical Global Impression) Scale – NIMH. Psychopharmacol Bull 1985;21:83944.
  • 32
    Ambrosini PJ. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry 2000;39:4958.
  • 33
    Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;212:1119.
  • 34
    Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672676.
  • 35
    Inada T, Matsuda G, Kitao Y, et al. Barnes Akathisia Scale: Usefulness of standardized videotape method in evaluation of the reliability and in training raters. Int J Methods Psychiatr Res 1996;6:4952.
  • 36
    Rapoport JL. DSM-III-R and pediatric psychopharmacology. Psychopharmacol Bull 1985;21:803806.
  • 37
    McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002;347:314321.